211
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Combined Effects Of Low Incubation Temperature, Minimal Growth Medium, And Low Hydrodynamics Optimize Acinetobacter baumannii Biofilm Formation

ORCID Icon & ORCID Icon
Pages 3523-3536 | Published online: 15 Nov 2019

References

  • Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int J Antimicrob Agents. 2015;45(6):568–585. doi:10.1016/j.ijantimicag.2015.03.00125857949
  • Gunn JS, Bakaletz LO, Wozniak DJ. What is on the outside matters: the role of the extracellular polymeric substance of Gram-negative biofilms in evading host immunity and as a target for therapeutic intervention. J Biol Chem. 2016;291(24):12538–12546. doi:10.1074/jbc.R115.70754727129225
  • Ciofu O, Rojo‐Molinero E, Macià MD, Oliver A. Antibiotic treatment of biofilm infections. APMIS. 2017;125(4):304–319. doi:10.1111/apm.1267328407419
  • Costerton JW, Cheng K, Geesey GG, et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol. 1987;41(1):435–464. doi:10.1146/annurev.mi.41.100187.0022513318676
  • Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–1322. doi:10.1126/science.284.5418.131810334980
  • Jamal M, Tasneem U, Hussain T, Andleeb S. Bacterial biofilm: its composition, formation and role in human infections. J Microbiol Biotechnol. 2015;4(3):1–15.
  • Davey ME, O’toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev. 2000;64(4):847–867. doi:10.1128/mmbr.64.4.847-867.200011104821
  • Eze EC, Chenia HY, El Zowalaty ME. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist. 2018;11:2277. doi:10.2147/IDR.S16989430532562
  • Whitehead NA, Barnard AM, Slater H, Simpson NJ, Salmond GP. Quorum-sensing in Gram-negative bacteria. FEMS Microbiol Immunol. 2001;25(4):365–404.
  • Li YH, Tian XL. Quorum sensing and bacterial social interactions in biofilms: In: de Bruijn FJ, editor. Bacterial cooperation and competition. Stress and Environmental Regulation of Gene Expression and Adaptation in Bacteria. New Jersey: John Wiley & Sons; 2016:1195–1205.
  • Irie Y, Parsek MR. Quorum sensing and microbial biofilms In: Romeo T, editor. Bacterial Biofilms. Verlag Berlin: Springer; 2008:67–84.
  • Horswill AR, Stoodley P, Stewart PS, Parsek MR. The effect of the chemical, biological, and physical environment on quorum sensing in structured microbial communities. Anal Bioanal Chem. 2007;387(2):371–380. doi:10.1007/s00216-006-0720-y17047948
  • Mediaswanti K. Influence of physicochemical aspects of substratum nanosurface on bacterial attachment for bone implant applications. J Nanotechnol. 2016;2016. doi:10.1155/2016/5026184
  • Regina VR, Lokanathan AR, Modrzyński JJ, Sutherland DS, Meyer RL. Surface physicochemistry and ionic strength affects eDNA’s role in bacterial adhesion to abiotic surfaces. PLoS One. 2014;9(8):e105033. doi:10.1371/journal.pone.010503325122477
  • Garrett TR, Bhakoo M, Zhang Z. Bacterial adhesion and biofilms on surfaces. Prog Nat Sci. 2008;18(9):1049–1056. doi:10.1016/j.pnsc.2008.04.001
  • Rochex A, Godon -J-J, Bernet N, Escudié R. Role of shear stress on composition, diversity and dynamics of biofilm bacterial communities. Water Res. 2008;42(20):4915–4922. doi:10.1016/j.watres.2008.09.01518945468
  • Kim J, Kim H-S, Han S, et al. Hydrodynamic effects on bacterial biofilm development in a microfluidic environment. Lab Chip. 2013;13(10):1846–1849. doi:10.1039/c3lc40802g23576069
  • Francino MP. The ecology of bacterial genes and the survival of the new. Int J Evol Biol. 2012;2012. doi:10.1155/2012/394026
  • López-Maury L, Marguerat S, Bähler J. Tuning gene expression to changing environments: from rapid responses to evolutionary adaptation. Nat Rev Genet. 2008;9(8):583. doi:10.1038/nrg239818591982
  • Tung J, Gilad Y. Social environmental effects on gene regulation. Cell Mol Life Sci. 2013;70(22):4323–4339. doi:10.1007/s00018-013-1357-623685902
  • Smoot LM, Smoot JC, Graham MR, et al. Global differential gene expression in response to growth temperature alteration in group A Streptococcus. Proc Natl Acad Sci. 2001;98(18):10416–10421. doi:10.1073/pnas.19126759811517341
  • Wright MS, Iovleva A, Jacobs MR, Bonomo RA, Adams MD. Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment. Genome Med. 2016;8(1):26. doi:10.1186/s13073-016-0279-y26939581
  • Goh HS, Beatson SA, Totsika M, et al. Molecular analysis of the Acinetobacter baumannii biofilm-associated protein. Appl Environ Microbiol. 2013;79(21):6535–6543. doi:10.1128/AEM.01402-1323956398
  • Basson A, Flemming L, Chenia H. Evaluation of adherence, hydrophobicity, aggregation, and biofilm development of Flavobacterium johnsoniae-like isolates. Microb Ecol. 2008;55(1):1–14. doi:10.1007/s00248-007-9245-y17401596
  • Moreau-Marquis S, Stanton BA, O’Toole GA. Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway. Pulm Pharmacol Ther. 2008;21(4):595–599. doi:10.1016/j.pupt.2007.12.00118234534
  • Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM, Donlan RM. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother. 2010;54(1):397–404. doi:10.1128/AAC.00669-0919822702
  • Antunes L, Visca P, Towner KJ. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis. 2014;71(3):292–301. doi:10.1111/2049-632X.1212524376225
  • Falagas M, Karveli E. The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications. Clin Microbiol Infect. 2007;13(2):117–119. doi:10.1111/j.1469-0691.2006.01596.x17328722
  • Camp C, Tatum OL. A review of Acinetobacter baumannii as a highly successful pathogen in times of war. Lab Med. 2010;41(11):649–657. doi:10.1309/LM90IJNDDDWRI3RE
  • Charnot-Katsikas A, Dorafshar AH, Aycock JK, David MZ, Weber SG, Frank KM. Two cases of necrotizing fasciitis due to Acinetobacter baumannii. J Clin Microbiol. 2009;47(1):258–263. doi:10.1128/JCM.01250-0818923009
  • Jawad A, Hawkey PM, Heritage J, Snelling AM. Description of Leeds Acinetobacter Medium, a new selective and differential medium for isolation of clinically important Acinetobacter spp., and comparison with Herellea agar and Holton's agar.. J Clin Microbiol. 1994Oct;32(10):2353–8.7814465
  • Lee HW, Koh Y, Kim J, et al. Capacity of multidrug‐resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. J Clin Microbiol Infect. 2008;14(1):49–54. doi:10.1111/j.1469-0691.2007.01842.x
  • Kaiser TDL, Pereira EM, Dos Santos KRN, Maciel ELN, Schuenck RP, Nunes APF. Modification of the Congo red agar method to detect biofilm production by Staphylococcus epidermidis. Diagn Microbiol Infect Dis. 2013;75(3):235–239. doi:10.1016/j.diagmicrobio.2012.11.01423313084
  • Patel J, Cockerill F, Bradford P, et al. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically Approved standard M07-A10, Wayne, PA; USA. 2016.
  • Stepanović S, Vuković D, Dakić I, Savić B, Švabić-Vlahović M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40(2):175–179.10699673
  • Qi L, Li H, Zhang C, et al. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii. Front Microbiol. 2016;7:483. doi:10.3389/fmicb.2016.0048327148178
  • Stepanović S, Vuković D, Hola V, et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by Staphylococci. APMIS. 2007;115(8):891–899. doi:10.1111/j.1600-0463.2007.apm_630.x17696944
  • Van Houdt R, Aertsen A, Jansen A, Quintana A, Michiels C. Biofilm formation and cell‐to‐cell signalling in Gram‐negative bacteria isolated from a food processing environment. J Appl Microbiol. 2004;96(1):177–184. doi:10.1046/j.1365-2672.2003.02131.x14678172
  • Kollef MH, Niederman MS. Why is Acinetobacter baumannii a problem for critically ill patients? Intensive Care Med. 2015;41(12):2170–2172. doi:10.1007/s00134-015-4096-326474995
  • Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(10):3471–3484. doi:10.1128/AAC.01464-0617646423
  • Zhang C, Qiu S, Wang Y, et al. Higher isolation of NDM-1 producing Acinetobacter baumannii from the sewage of the hospitals in Beijing. PLoS One. 2013;8(6):e64857. doi:10.1371/journal.pone.006485723755152
  • Hrenovic J, Goic-Barisic I, Kazazic S, Kovacic A, Ganjto M, Tonkic M. Carbapenem-resistant isolates of Acinetobacter baumannii in a municipal wastewater treatment plant, Croatia, 2014. Euro Surveill. 2016;21(15):30195. doi:10.2807/1560-7917.ES.2016.21.15.30195
  • Zhang Y, Marrs CF, Simon C, Xi C. Wastewater treatment contributes to selective increase of antibiotic resistance among Acinetobacter spp. Sci Total Environ. 2009;407(12):3702–3706. doi:10.1016/j.scitotenv.2009.02.01319321192
  • Kizny Gordon AE, Mathers AJ, Cheong EY, et al. The hospital water environment as a reservoir for carbapenem-resistant organisms causing hospital-acquired infections—a systematic review of the literature. Clin Infect Dis. 2017;64(10):1435–1444. doi:10.1093/cid/cix13228200000
  • Nucleo E, Steffanoni L, Fugazza G, et al. Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii. BMC Microbiol. 2009;9(1):270. doi:10.1186/1471-2180-9-27020028528
  • Kentache T, Abdelkrim AB, Jouenne T, De E, Hardouin J. Global dynamic proteome study of a pellicle-forming Acinetobacter baumannii strain. Mol Cell Proteomics. 2017;16(1):100–112. doi:10.1074/mcp.M116.06104427799293
  • Thomen P, Robert J, Monmeyran A, Bitbol A-F, Douarche C, Henry N. Bacterial biofilm under flow: first a physical struggle to stay, then a matter of breathing. PLoS One. 2017;12(4):e0175197. doi:10.1371/journal.pone.017519728403171
  • Pour NK, Dusane DH, Dhakephalkar PK, Zamin FR, Zinjarde SS, Chopade BA. Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters. FEMS Immunol Med Microbiol. 2011;62(3):328–338. doi:10.1111/j.1574-695X.2011.00818.x21569125
  • Pruthi V, Al-Janabi A, Pereira BJ. Characterization of biofilm formed on intrauterine devices. Indian J Med Microbiol. 2003;21(3):161.17643011
  • De Silva PM, Chong P, Fernando DM, Westmacott G, Kumar A. Effect of incubation temperature on antibiotic resistance and virulence factors of Acinetobacter baumannii ATCC 17978. Antimicrob Agents Chemother. 2018;62(1):e01514–e01517.29061747
  • Lambert G, Bergman A, Zhang Q, Bortz D, Austin R. Physics of biofilms: the initial stages of biofilm formation and dynamics. New J Phys. 2014;16(4):045005. doi:10.1088/1367-2630/16/4/045005
  • Hassan A, Usman J, Kaleem F, Omair M, Khalid A, Iqbal M. Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz J Infect Dis. 2011;15(4):305–311.21860999
  • Kumari AMS, Routray A, Yadav D, Madhavan R. Imipenem resistance and biofilm production in Acinetobacter. Drug Invent Today. 2013;5(3):256–258. doi:10.1016/j.dit.2013.04.005
  • Bocanegra-Ibarias P, Pena-López C, Camacho-Ortiz A, et al. Genetic characterisation of drug resistance and clonal dynamics of Acinetobacter baumannii in a hospital setting in Mexico. Int J Antimicrob Agents. 2015;45(3):309–313. doi:10.1016/j.ijantimicag.2014.10.02225561030
  • Guo H, Xiang J. Influences of abaR gene on biofilm formation of Acinetobacter baumannii. Zhonghua Shao Shang Za Zhi. 2017;33(4):200–205. doi:10.3760/cma.j.issn.1009-2587.2017.04.00328427132
  • Wroblewska MM, Sawicka-Grzelak A, Marchel H, Luczak M, Sivan A. Biofilm production by clinical strains of Acinetobacter baumannii isolated frompatients hospitalized in two tertiary care hospitals. FEMS Immunol Med Microbiol. 2008;53(1):140–144. doi:10.1111/j.1574-695X.2008.00403.x18400015
  • de Campos PA, Royer S, Da Fonseca Batistao DW, et al. Multidrug resistance related to biofilm formation in Acinetobacter baumannii and Klebsiella pneumoniae clinical strains from different pulsotypes. Curr Microbiol. 2016;72(5):617–627. doi:10.1007/s00284-016-0996-x26846651
  • Thummeepak R, Kongthai P, Leungtongkam U, Sitthisak S. Distribution of virulence genes involved in biofilm formation in multi-drug resistant Acinetobacter baumannii clinical isolates. Int Microbiol. 2016;19(2):121–129. doi:10.2436/20.1501.01.27027845499
  • Abdi-Ali A, Hendiani S, Mohammadi P, Gharavi S. Assessment of biofilm formation and resistance to imipenem and ciprofloxacin among clinical isolates of Acinetobacter baumannii in Tehran. Jundishapur J Microbiol. 2014;7:1. doi:10.5812/jjm